ATE400290T1 - Pharmazeutische zusammensetzung mit einem nicht- detergens sulfobetain - Google Patents
Pharmazeutische zusammensetzung mit einem nicht- detergens sulfobetainInfo
- Publication number
- ATE400290T1 ATE400290T1 AT04809251T AT04809251T ATE400290T1 AT E400290 T1 ATE400290 T1 AT E400290T1 AT 04809251 T AT04809251 T AT 04809251T AT 04809251 T AT04809251 T AT 04809251T AT E400290 T1 ATE400290 T1 AT E400290T1
- Authority
- AT
- Austria
- Prior art keywords
- pharmaceutical composition
- detergent
- sulfobetain
- composition containing
- ndsb
- Prior art date
Links
- 239000003599 detergent Substances 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- IZWSFJTYBVKZNK-UHFFFAOYSA-O N-dodecyl-N,N-dimethyl-3-ammonio-1-propanesulfonic acid Chemical compound CCCCCCCCCCCC[N+](C)(C)CCCS(O)(=O)=O IZWSFJTYBVKZNK-UHFFFAOYSA-O 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/193—Colony stimulating factors [CSF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SI200300318A SI21639A (sl) | 2003-12-23 | 2003-12-23 | Farmacevtski pripravek, ki vsebuje nemicelarne sulfobetaine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE400290T1 true ATE400290T1 (de) | 2008-07-15 |
Family
ID=34709498
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04809251T ATE400290T1 (de) | 2003-12-23 | 2004-12-22 | Pharmazeutische zusammensetzung mit einem nicht- detergens sulfobetain |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US7906109B2 (de) |
| EP (1) | EP1729794B1 (de) |
| JP (1) | JP4971798B2 (de) |
| CN (1) | CN1897967B (de) |
| AT (1) | ATE400290T1 (de) |
| AU (1) | AU2004305421B2 (de) |
| BR (1) | BRPI0417265A (de) |
| CA (1) | CA2545632C (de) |
| DE (1) | DE602004014991D1 (de) |
| ES (1) | ES2308292T3 (de) |
| RU (1) | RU2380112C2 (de) |
| SI (2) | SI21639A (de) |
| WO (1) | WO2005060989A1 (de) |
| ZA (1) | ZA200604657B (de) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101116670B (zh) * | 2006-08-01 | 2010-11-10 | 广州和竺生物科技有限公司 | 可提供活性甲基或参与甲基转移的化合物作为制备治疗病毒性疾病的药的应用 |
| AU2007234612B2 (en) | 2006-12-14 | 2013-06-27 | Johnson & Johnson Regenerative Therapeutics, Llc | Protein stabilization formulations |
| US7678764B2 (en) | 2007-06-29 | 2010-03-16 | Johnson & Johnson Regenerative Therapeutics, Llc | Protein formulations for use at elevated temperatures |
| CN101801405A (zh) | 2007-08-07 | 2010-08-11 | 先进科技及再生医学有限责任公司 | 包含于酸性水溶液中的gdf-5的蛋白质配方 |
| JP5599778B2 (ja) | 2008-04-14 | 2014-10-01 | デピュイ・シンセス・プロダクツ・エルエルシー | 液体緩衝ｇｄｆ−５製剤 |
| RU2435589C2 (ru) * | 2009-06-02 | 2011-12-10 | Федеральное государственное учреждение "Государственный научный центр дерматовенерологии и косметологии" Министерства здравоохранения и социального развития Российской Федерации (ФГУ "ГНЦДК Минздравсоцразвития России) | Состав консервирующей добавки к контрольным материалам, используемым при серодиагностике сифилиса |
| UY34105A (es) | 2011-06-03 | 2012-07-31 | Lg Life Sciences Ltd | Formulación líquida estable de etanercept |
| BR112014009866A2 (pt) | 2011-10-25 | 2018-09-04 | Onclave Therapeutics Limited | formulações de anticorpos e métodos |
| GB201315321D0 (en) * | 2013-08-28 | 2013-10-09 | Koninklijke Nederlandse Akademie Van Wetenschappen | Transduction Buffer |
| WO2015079977A1 (ja) * | 2013-11-26 | 2015-06-04 | シャープ株式会社 | 抗体分離方法、抗体評価方法、医薬の評価方法、及び、抗体の２次元電気泳動用キット |
| GB201521101D0 (en) | 2015-11-30 | 2016-01-13 | Koninklijke Nederlandse Akademie Van Wetenschappen | Transduction buffer |
| CN112933039A (zh) * | 2019-12-11 | 2021-06-11 | 深圳赛保尔生物药业有限公司 | 一种重组人促红细胞生成素液体制剂 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4470919A (en) * | 1982-02-03 | 1984-09-11 | The Procter & Gamble Company | Oxygen-bleach-containing liquid detergent compositions |
| KR900007659B1 (ko) * | 1987-02-23 | 1990-10-18 | 시세이도 가부시끼가이샤 | 경피 흡수촉진제 및 이를 함유하는 피부외용 제제 |
| NZ236819A (en) * | 1990-02-03 | 1993-07-27 | Max Planck Gesellschaft | Enzymatic cleavage of fusion proteins; fusion proteins; recombinant dna and pharmaceutical compositions |
| DE4242863A1 (de) * | 1992-12-18 | 1994-06-23 | Boehringer Mannheim Gmbh | Stabile lyophilisierte pharmazeutische Zubereitungen von G-CSF |
| US5550416A (en) * | 1995-02-09 | 1996-08-27 | Fanchang; We C. | Control mechanism of revolving speed of an electric tool |
| DE19549232C2 (de) * | 1995-12-20 | 1998-05-20 | Boehringer Mannheim Gmbh | Verwendung von G-CSF in Kombination mit einem Chemotherapeutikum bei der Behandlung von Erkrankungen, die eine periphere Stammzelltransplantation erfordern |
| CA2242411A1 (en) * | 1996-01-12 | 1997-07-17 | The Procter & Gamble Company | Disinfecting compositions and processes for disinfecting surfaces |
| US6103683A (en) * | 1996-01-12 | 2000-08-15 | The Procter & Gamble Co. | Disinfecting compositions and processes for disinfecting surfaces |
| TR199801336T2 (xx) * | 1996-02-23 | 1998-10-21 | The Procter & Gamble Company | Dezenfekte edici bile�imler. |
| SE9801288D0 (sv) * | 1998-04-14 | 1998-04-14 | Astra Ab | Vaccine delivery system and metod of production |
| SI21273A (sl) * | 2002-07-31 | 2004-02-29 | LEK farmacevtska dru�ba d.d. | Priprava inkluzijskih teles z visokim deležem pravilno zvitega prekurzorja heterolognega proteina |
-
2003
- 2003-12-23 SI SI200300318A patent/SI21639A/sl not_active IP Right Cessation
-
2004
- 2004-12-22 EP EP04809251A patent/EP1729794B1/de not_active Expired - Lifetime
- 2004-12-22 SI SI200430881T patent/SI1729794T1/sl unknown
- 2004-12-22 ES ES04809251T patent/ES2308292T3/es not_active Expired - Lifetime
- 2004-12-22 CA CA2545632A patent/CA2545632C/en not_active Expired - Fee Related
- 2004-12-22 US US10/583,157 patent/US7906109B2/en not_active Expired - Fee Related
- 2004-12-22 RU RU2006126784/15A patent/RU2380112C2/ru not_active IP Right Cessation
- 2004-12-22 AT AT04809251T patent/ATE400290T1/de active
- 2004-12-22 CN CN200480038901.4A patent/CN1897967B/zh not_active Expired - Fee Related
- 2004-12-22 AU AU2004305421A patent/AU2004305421B2/en not_active Ceased
- 2004-12-22 WO PCT/SI2004/000043 patent/WO2005060989A1/en not_active Ceased
- 2004-12-22 BR BRPI0417265-5A patent/BRPI0417265A/pt not_active IP Right Cessation
- 2004-12-22 JP JP2006546933A patent/JP4971798B2/ja not_active Expired - Fee Related
- 2004-12-22 DE DE602004014991T patent/DE602004014991D1/de not_active Expired - Lifetime
-
2006
- 2006-06-07 ZA ZA200604657A patent/ZA200604657B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2545632C (en) | 2014-10-14 |
| EP1729794B1 (de) | 2008-07-09 |
| CA2545632A1 (en) | 2005-07-07 |
| AU2004305421B2 (en) | 2010-07-08 |
| SI21639A (sl) | 2005-06-30 |
| CN1897967A (zh) | 2007-01-17 |
| CN1897967B (zh) | 2010-09-08 |
| JP4971798B2 (ja) | 2012-07-11 |
| DE602004014991D1 (de) | 2008-08-21 |
| US20070184019A1 (en) | 2007-08-09 |
| BRPI0417265A (pt) | 2007-03-06 |
| AU2004305421A1 (en) | 2005-07-07 |
| US7906109B2 (en) | 2011-03-15 |
| ES2308292T3 (es) | 2008-12-01 |
| EP1729794A1 (de) | 2006-12-13 |
| RU2380112C2 (ru) | 2010-01-27 |
| JP2007516281A (ja) | 2007-06-21 |
| WO2005060989A1 (en) | 2005-07-07 |
| RU2006126784A (ru) | 2008-01-27 |
| SI1729794T1 (sl) | 2008-12-31 |
| ZA200604657B (en) | 2007-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1108547T1 (el) | Αναλογα σωματοστατινης | |
| EP1506786A4 (de) | Medizinische, ghrelin enthaltende zusammensetzungen | |
| EP1603593A4 (de) | Pharmazeutische zusammensetzung | |
| ATE320244T1 (de) | Pharmazeutische zusammensetzungen mit amlodipinmaleat | |
| ATE480518T1 (de) | Chemische verbindung | |
| EP1425019A4 (de) | Pharmazeutische zusammensetzung | |
| PT1467724E (pt) | Composicao farmaceutica orodispersavel de agomelatina | |
| DK1596870T4 (da) | Højdosis-ibandronatformulering | |
| DE602004014991D1 (de) | Pharmazeutische zusammensetzung mit einem nicht-detergens sulfobetain | |
| DE60320902D1 (de) | Zusammensetzungen mit ausgelöster Freisetzung | |
| ATE477814T1 (de) | Stabile faktor-viii enthaltende pharmazeutische zusammensetzung | |
| DE60211183D1 (de) | Pharmazeutische zusammensetzung enthaltend lumiracoxib | |
| BRPI0417950A (pt) | composições farmacêuticas | |
| DE60217390D1 (de) | Bicalutamid enthaltende pharmazeutische zusammensetzung | |
| EP1611147A4 (de) | 6"-amino-6"-deoxygalactosylceramide | |
| BRPI0408446A (pt) | tablete de limpeza | |
| NO20063293L (no) | Farmasoytiske forbindelser | |
| DE602004027808D1 (de) | Tablette enthaltend fluvastatin und calciumcarmellose | |
| DE602004022420D1 (de) | Pharmazeutische zusammensetzungen, die cyclische somatostatinanaloga enthalten | |
| DE10291905D2 (de) | Pharmazeutische Zusammensetzung | |
| IS7581A (is) | Lyfjasamsetning | |
| ATE350029T1 (de) | Pharmazeutische zusammensetzung enthaltend gamma- butyrobetain | |
| DE602004016751D1 (de) | Orodispersible pharmazeutische zusammensetzung einer antithrombotischen verbindung | |
| DE60216332D1 (de) | Antioxydationsmittel aus natürlicher quelle | |
| DE10107261B4 (de) | Pharmazeutische Zusammensetzung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1729794 Country of ref document: EP |